C07K 14/4702
Regulators
Official title: {Regulators; Modulating activity}
C07K14/4702 (Regulators) appears on 4,674 US grants and 7,332 published applications in this corpus.
Search patents in C07K- Granted patents
- 4,674
- Published applications
- 7,332
- Assignees
- 2,423
- Inventors
- 13,023
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 5 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 7 | 0 |
| 1990 | 8 | 0 |
| 1991 | 7 | 0 |
| 1992 | 22 | 0 |
| 1993 | 21 | 0 |
| 1994 | 29 | 0 |
| 1995 | 27 | 0 |
| 1996 | 59 | 0 |
| 1997 | 101 | 0 |
| 1998 | 175 | 0 |
| 1999 | 193 | 0 |
| 2000 | 158 | 0 |
| 2001 | 173 | 15 |
| 2002 | 173 | 340 |
| 2003 | 133 | 921 |
| 2004 | 124 | 320 |
| 2005 | 106 | 317 |
| 2006 | 146 | 244 |
| 2007 | 222 | 224 |
| 2008 | 187 | 200 |
| 2009 | 122 | 223 |
| 2010 | 143 | 225 |
| 2011 | 124 | 186 |
| 2012 | 126 | 183 |
| 2013 | 134 | 185 |
| 2014 | 110 | 193 |
| 2015 | 140 | 217 |
| 2016 | 130 | 261 |
| 2017 | 158 | 227 |
| 2018 | 148 | 273 |
| 2019 | 162 | 240 |
| 2020 | 162 | 280 |
| 2021 | 161 | 339 |
| 2022 | 177 | 385 |
| 2023 | 130 | 321 |
| 2024 | 177 | 376 |
| 2025 | 171 | 372 |
| 2026 | 104 | 265 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Protein with anti-inflammatory properties6 Oct 2026US 12,753,214 B2Revolo Biotherapeutics Limited
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Compositions and methods for selective protein degradation29 Sep 2026US 12,747,272 B2Novartis AG
- HTT repressors comprising a zinc-finger protein transcription factor29 Sep 2026US 12,747,273 B2Sangamo Therapeutics, Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Targeting gpatch8 for treating sf3b1-mutant cancers8 Oct 2026US 2026/0306672 A1Fred Hutchinson Cancer Center
- Il-1ra cdnas8 Oct 2026US 2026/0308211 A1University of Florida Research Foundation, Inc.
- Engineered cells with enhanced tead protein transcriptional activities and methods of use thereof8 Oct 2026US 2026/0308517 A1Legend Biotech USA Inc.
Most cited
By later US patents
- Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites556US 6,453,242 B1Sangamo BioSciences, Inc. · 2002
- Binding proteins for recognition of DNA434US 6,007,988 AMedical Research Council · 1999
- Binding proteins for recognition of DNA423US 6,013,453 AMedical Research Council · 2000
- Zinc finger proteins with high affinity new DNA binding specificities409US 5,789,538 AMassachusetts Institute of Technology · 1998
- Zinc finger binding domains for GNN396US 6,140,081 AThe Scripps Research Institute · 2000